Circulating tumor DNA–defined minimal residual disease in solid tumors: Opportunities to accelerate the development of adjuvant therapies

Arvind Dasari, Axel F Grothey, Scott Kopetz

Research output: Contribution to journalComment/debate

9 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)3437-3440
Number of pages4
JournalJournal of Clinical Oncology
Volume36
Issue number35
DOIs
StatePublished - Dec 10 2018
Externally publishedYes

Fingerprint

Residual Neoplasm
DNA
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Circulating tumor DNA–defined minimal residual disease in solid tumors : Opportunities to accelerate the development of adjuvant therapies. / Dasari, Arvind; Grothey, Axel F; Kopetz, Scott.

In: Journal of Clinical Oncology, Vol. 36, No. 35, 10.12.2018, p. 3437-3440.

Research output: Contribution to journalComment/debate

@article{36c0a759098d4f05b8d5fa4b4c8f8477,
title = "Circulating tumor DNA–defined minimal residual disease in solid tumors: Opportunities to accelerate the development of adjuvant therapies",
author = "Arvind Dasari and Grothey, {Axel F} and Scott Kopetz",
year = "2018",
month = "12",
day = "10",
doi = "10.1200/JCO.2018.78.9032",
language = "English (US)",
volume = "36",
pages = "3437--3440",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "35",

}

TY - JOUR

T1 - Circulating tumor DNA–defined minimal residual disease in solid tumors

T2 - Opportunities to accelerate the development of adjuvant therapies

AU - Dasari, Arvind

AU - Grothey, Axel F

AU - Kopetz, Scott

PY - 2018/12/10

Y1 - 2018/12/10

UR - http://www.scopus.com/inward/record.url?scp=85058280775&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058280775&partnerID=8YFLogxK

U2 - 10.1200/JCO.2018.78.9032

DO - 10.1200/JCO.2018.78.9032

M3 - Comment/debate

AN - SCOPUS:85058280775

VL - 36

SP - 3437

EP - 3440

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 35

ER -